CoQ10 deficiency can present in infancy as a severe encephalomyopathy or multisystemic mitochondrial disease, with features such as hypotonia, developmental delay, intractable seizures, lactic acidosis, cardiomyopathy, and failure to thrive. Reports of infantile‑onset multisystem CoQ10 deficiency describe very early presentations, sometimes in the neonatal period, with rapid neurologic deterioration and involvement of brain, heart, kidney, and liver, and many affected children die in the first months or years of life despite intensive care. The important clinical point is that, although outcomes are often poor in the most severe cases, some infants and young children show neurologic improvement or stabilization when CoQ10 deficiency is recognized early and high‑dose CoQ10 supplementation is started promptly, which is why this diagnosis is considered a treatable cause of infantile encephalomyopathy This medication is commonly used for Depression.
Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev. 2010;16(2):183-8. Chen RS, Huang CC, Chu NS. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur Neurol. 1997;37(4):212-8. Boitier E, Degoul F, Desguerre I, Charpentier C, François D, Ponsot G, Diry M, Rustin P, Marsac C. A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci. 1998;156(1):41-6. Sobreira C, Hirano M, Shanske S, Keller RK, Haller RG, Davidson E, Santorelli FM, Miranda AF, Bonilla E, Mojon DS, Barreira AA, King MP, DiMauro S. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology. 1997 May;48(5):1238-43.
Some side effects may be linked to nutrient depletion caused by this medication.
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a vital nutrient found in nearly every cell in the body. CoQ10 plays a key role in cellular energy production, acting within the mitochondria, the powerhouses of our cells. Research suggests a connection between mitochondrial dysfunction and depression, and this dysfunction might even be worsened by some antidepressant medications like amitriptyline. It found that tricyclic amines such as amitriptyline treatment in human cells decreased the levels of CoQ10. Supplementation with COQ10 could help improve overall cellular health and potentially alleviate symptoms associated with mitochondrial dysfunction in depression.
Vitamin B2 (Riboflavin) may play a role in mood regulation, particularly in older adults. Research has found an association between higher dietary intake of vitamin B2 and lower scores on a depression scale (Geriatric Depression Scale) in elderly individuals. Vitamin B2 converts food into energy, which is essential for all bodily functions, including brain function. Deficiencies can lead to fatigue and low mood. It is also involved in the production of neurotransmitters, the chemical messengers in the brain that influence mood. Deficiencies in some neurotransmitters are linked to depression. Supplementation with vitamin B2 may help support mood and protect against depression.
Research on the connection between vitamin B3 (niacin) and depression is growing. Studies suggest that people who met the recommended dietary allowance (RDA) for niacin had a significantly lower risk of depression compared to those with lower intake. Vitamin B3 plays a role in converting food into energy, which is essential for brain function and overall well-being. Deficiencies can lead to fatigue and low mood. Some research suggests vitamin B3 might be involved in the production of neurotransmitters like serotonin, which plays a role in mood regulation. Deficiencies in some neurotransmitters are linked to depression. Supplementation with vitamin B3 may help support mood and protect against depression.